Skip to content

Effect of Bilwa or bael and Spinach based toothpaste in the reducing tooth sensitivity.

Comparative evaluation of Desensitizing effect of Aegle marmelos toothpaste, Spinacia oleracea toothpaste and their combination with commercially available desensitizing toothpaste: A Double-blinded Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067196
Enrollment
100
Registered
2024-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K038- Other specified diseases of hard tissues of teeth

Interventions

Intervention1: Aegle marmelos toothpaste,Spinacia oleracea toothpaste and their combination: To be used as a toothpaste for brushing twice daily, morning and night, 2 minutes for a period of 4 weeks i

Sponsors

Dr Yuvarani K P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients in the age group of 20–50 years 2)Patients with a minimum of two hypersensitive teeth which are anterior to molars and demonstrated signs of facial/cervical erosion, abrasion, and/or gingival recession. 3)The study teeth must be caries-free and with no restorations; 4)Patients who haven’t used any desensitizing toothpaste within the last 3 months 5)Patients with either no clinical mobility or grade I mobility will be included. 6)Patients who are willing to be available during the duration of the study and to sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1)Patients with gross underlying pathologies. 2)Subjects with any other systemic/psychological conditions. 3)Pregnant and lactating females will be excluded 4)Development alterations like hypoplasia or fluorosis. 5)Use of orthodontic device or appliance 6)Subjects with any history of allergy reactions to herbal medicaments or toothpaste 7)Subjects suffering from a chronic medical disease or conditions which are associated with intermittent episodes or constant daily pain 8)Subjects who are taking certain medications (anti-inflammatory drugs or antibiotics) daily during the previous 7 days; 9)Subjects who are unwilling to complete the treatment protocol.

Design outcomes

Primary

MeasureTime frame
Assessment of dentin hypersensitivity using tactile stimulus and thermal stimulus test which includes air-blast, cold, and application of an acidic solutionTimepoint: 2nd week and 4th week

Secondary

MeasureTime frame
Visual analog scale and schiff scoreTimepoint: 2nd week and 4th week

Countries

India

Contacts

Public ContactDrRoopali M Sankeshwari

KAHER’s KLE Vishwanath Katti Institute of Dental Sciences

yuvasrikpyk@gmail.com07639270619

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026